Three diseases. One mission. Roche combines breakthrough technologies with deep immunology expertise and real-world data to transform treatment for lupus, IBD, and COPD
Scott, an HR professional and coach in Basel, suddenly found himself in uncharted territory—facing medical uncertainty and personal resilience. As a passionate part-time drummer, he's determined not to miss a beat in his search for answers.
For more than 50 years, Roche has been committed to Parkinson’s research. Today, progress is bringing us closer to treatments that could slow progression and help people stay independent for longer.
Roche researchers are working on diagnostic innovations to improve the Alzheimer’s patient journey. One of the most promising areas is the development of simple, accurate blood technologies that can detect key biomarkers associated with the disease.
In February 2026, Roche opened its new Diagnostics Innovation Center in Penzberg, Germany. Roche is establishing a modern and sustainable research and development center for approximately 1,000 employees.
Learn how the amdARRAY, a global collaboration between Roche and leading academic institutions, is accelerating research in age-related macular degeneration (AMD).
Scientists review progress in the field of organoid technology and exciting future opportunities to apply these human model systems in industry settings.
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)
:quality(90)/)